5-Aminosalicylate (5-ASA) Induced Nephrotoxicity in Inflammatory Bowel Disease

被引：0
|
作者：
So, Kenji
Bewshea, Claire M.
Heap, Graham A.
Muller, Andrew F.
Delaney, Michael P.
Daneshmend, Tawfique K.
Hart, Ailsa L.
Orchard, Timothy R.
Irving, Peter M.
D'Souza, Richard
Mulgrew, Chris
Kwan, Jonathan
Silverberg, Mark S.
Gearry, Richard B.
Radford-Smith, Graham
Watermeyer, Gillian
D'Inca, Renata
Annese, Vito
Tsianos, Epameinondas V.
Russell, Richard K.
Wilson, David C.
Parkes, Miles
Satsangi, Jack
Oram, Richard A.
Weersma, Rinse K.
Lawrance, Ian C.
Holden, Arthur L.
Lees, Charlie W.
Ahmad, Tariq
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [1] 5-AMINOSALICYLATE (5-ASA) INDUCED NEPHROTOXICITY IN INFLAMMATORY BOWEL DISEASE
    So, K.
    Bewshea, C.
    Heap, G. A.
    Muller, A. F.
    Daneshmend, T. K.
    Hart, A. L.
    Orchard, T. R.
    Irving, P. M.
    Russell, R. K.
    Wilson, D. C.
    Parkes, M.
    Satsangi, J.
    Lees, C. W.
    Ahmad, T.
    GUT, 2013, 62 : A22 - A22
  • [2] Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease
    Heap, Graham A.
    So, Kenji
    Weedon, Mike
    Edney, Naomi
    Bewshea, Claire
    Singh, Abhey
    Annese, Vito
    Beckly, John
    Buurman, Dorien
    Chaudhary, Rakesh
    Cole, Andrew T.
    Cooper, Sheldon C.
    Creed, Tom
    Cummings, Fraser
    de Boer, Nanne K.
    D'Inca, Renata
    D'Souza, Richard
    Daneshmend, Tawfique K.
    Delaney, Michael
    Dhar, Anjan
    Direkze, Natalie
    Dunckley, Paul
    Gaya, Daniel R.
    Gearry, Richard
    Gore, Steve
    Halfvarson, Jonas
    Hart, Ailsa
    Hawkey, Chris J.
    Hoentjen, Frank
    Iqbal, Tariq
    Irving, Peter
    Lal, Simon
    Lawrence, Ian
    Lees, Charlie W.
    Lewis, Steve
    Lockett, Melanie
    Mann, Stephen
    Mansfield, John
    Mowat, Craig
    Mulgrew, Chris J.
    Muller, Frank
    Murray, Charles
    Oram, Richard
    Orchard, Tim
    Parkes, Miles
    Phillips, Rosemary
    Pollok, Richard
    Radford-Smith, Graham
    Sebastian, Shaji
    Sen, Sandip
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (02): : 149 - 158
  • [3] A genome wide association study identifying association of the MHC region with 5-aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease
    Heap, G.
    Bewshea, C.
    Singh, A.
    Weedon, M.
    Goldstein, J.
    Ebney, N.
    Mulgrew, C.
    D'Souza, R.
    Oram, R.
    Orchard, T.
    Shirazi, T.
    Wesley, E.
    So, K.
    Wesley, E.
    Irving, P.
    Cole, A.
    Sebastian, S.
    Gaya, D.
    Lees, C.
    Lawrence, I.
    Hawkey, C.
    Mansfield, J.
    Parkes, M.
    Radford-Smith, G.
    Tsianos, E.
    Annese, V.
    Sturniolo, G. C.
    Weersma, R.
    D'Amato, M.
    Silverberg, M.
    Hart, A.
    Holden, A.
    Ahmad, T.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S19 - S20
  • [4] Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)induced Nephrotoxicity in Inflammatory Bowel Disease (vol 10, pg 149, 2016)
    Heap, Graham A.
    So, Kenji
    Weedon, Mike
    Edney, Naomi
    Bewshea, Claire
    Singh, Abhey
    Annese, Vito
    Beckly, John
    Buurman, Dorien
    Chaudhary, Rakesh
    Lawrance, Ian
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (12): : 1509 - 1509
  • [5] Effect of 5-aminosalicylate (5-ASA) on the recurrence rate of sporadic colorectal adenomas
    Schmiegel, W
    Pox, CP
    Reiser, M
    GASTROENTEROLOGY, 2004, 126 (04) : A452 - A452
  • [6] 5-AMINOSALICYLATE AND CHRONIC INFLAMMATORY BOWEL-DISEASE IN CHILDREN
    KLOTZ, U
    KLINISCHE PADIATRIE, 1995, 207 (05): : 285 - 287
  • [7] Indications for 5-aminosalicylate in inflammatory bowel disease:Is the body of evidence complete?
    Ad A van Bodegraven
    Chris JJ Mulder
    World Journal of Gastroenterology, 2006, (38) : 6115 - 6123
  • [8] Persistence to oral 5-aminosalicylate therapy for inflammatory bowel disease in Australia
    Selinger, Christian P.
    Kemp, Andrew
    Leong, Rupert W. L.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (03) : 329 - 334
  • [9] Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete?
    van Bodegraven, Ad A.
    Mulder, Chris J. J.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (38) : 6115 - 6123
  • [10] Does the 5-Aminosalicylate Concentration Correlate with the Efficacy of Oral 5-Aminosalicylate and Predict Response in Patients with Inflammatory Bowel Disease? A Systematic Review
    van de Meeberg, Maartje M.
    Schultheiss, Johannes P. D.
    Oldenburg, Bas
    Fidder, Herma H.
    Huitema, Alwin D. R.
    DIGESTION, 2020, 101 (03) : 245 - 261
12345